AlphaFold predicted structure
THPO · P40225

Mean pLDDT
61.4/ 100
Low
353 residues
Confidence breakdown
- Very high(≥ 90)23%
- Confident(70–90)20%
- Low(50–70)7%
- Very low(< 50)51%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
thrombopoietin
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCytopenia - NOT Fanconi anaemia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedInherited bleeding disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownThrombocythaemia
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownLimb disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedVACTERL-like phenotypes
thrombocythemia 1
amegakaryocytic thrombocytopenia, congenital, 2
thrombocytopenia 9
Thrombocytopenia
congenital amegakaryocytic thrombocytopenia 1
congenital amegakaryocytic thrombocytopenia
thrombocytopenia 4
hereditary disease
familial thrombocytosis
essential thrombocythemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Thrombopoietin
Lineage-specific cytokine affecting the proliferation and maturation of megakaryocytes from their committed progenitor cells. It acts at a late stage of megakaryocyte development. It may be the major physiological regulator of circulating platelets
THPO · P40225

Mean pLDDT
61.4/ 100
Low
353 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0